A

Aptevo Therapeutics
D

APVO

4.60000
USD
0.15
(3.37%)
Market Closed
Volume
0
EPS
-456
Div Yield
-
P/E
-0
Market Cap
2,301,504
OverviewSignalsIdeasNews
Related Instruments
    A
    ADMA
    0.285
    (1.63%)
    17.725 USD
    A
    APLT
    -0.00410
    (-0.47%)
    0.87600 USD
    A
    ASND
    3.770
    (2.77%)
    139.880 USD
    K
    KURA
    -0.07000
    (-0.78%)
    8.94000 USD
    L
    LGND
    -1.270
    (-1.11%)
    113.530 USD
    M
    MRKR
    -0.21000
    (-5.79%)
    3.42000 USD
    O
    OCUL
    0.06000
    (0.71%)
    8.56000 USD
    R
    RIGL
    0.070
    (0.41%)
    17.120 USD
    More
News

Title: Aptevo Therapeutics Inc

Sector: Healthcare
Industry: Biotechnology
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.